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OBJECTIVEdTo forecast the number of U.S. individuals aged,20 years with type 1 diabetes
mellitus (T1DM) or type 2 diabetes mellitus (T2DM) through 2050, accounting for changing
demography and diabetes incidence.
RESEARCHDESIGNANDMETHODSdWe used Markov modeling framework to gen-
erate yearly forecasts of the number of individuals in each of three states (diabetes, no diabetes, and
death). We used 2001 prevalence and 2002 incidence of T1DM and T2DM from the SEARCH for
Diabetes in Youth study and U.S. Census Bureau population demographic projections. Two sce-
narios were considered for T1DM and T2DM incidence: 1) constant incidence over time; 2) for
T1DMyearly percentage increases of 3.5, 2.2, 1.8, and 2.1%by age-groups 0–4 years, 5–9 years, 10–
14 years, and 15–19 years, respectively, and for T2DM a yearly 2.3% increase across all ages.
RESULTSdUnder scenario 1, the projected number of youth with T1DM rises from 166,018
to 203,382 and with T2DM from 20,203 to 30,111, respectively, in 2010 and 2050. Under scenario
2, the number of youth with T1DM nearly triples from 179,388 in 2010 to 587,488 in 2050
(prevalence 2.13/1,000 and 5.20/1,000 [+144% increase]), with the greatest increase in youth of
minority racial/ethnic groups. The number of youth with T2DM almost quadruples from 22,820 in
2010 to 84,131 in 2050; prevalence increases from 0.27/1,000 to 0.75/1,000 (+178% increase).
CONCLUSIONSdA linear increase in diabetes incidence could result in a substantial increase in the
number of youthwithT1DMandT2DMover thenext 40 years, especially those ofminority race/ethnicity.
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D iabetes is one of the most commonand costly chronic pediatric disea-ses (1). The SEARCH for Diabetes
in Youth study (SEARCH) estimated that
in 2001 about 154,000 individuals in the
U.S. aged ,20 years were living with di-
abetes and that each year approximately
15,000 youth aged ,20 years are being
diagnosed with type 1 diabetes mellitus
(T1DM) and 3,700 with type 2 diabetes
mellitus (T2DM) (2,3). Assessing the fu-
ture burden of diabetes in youth by dia-
betes type is crucial for implementing
public health primary and secondary pre-
vention programs and planning health
care delivery services.
A number of studies have estimated
the burden of diagnosed diabetes through
2050 in the U.S (4,5). A limitation is that
they were not able to separate the contri-
bution of T1DM from T2DM to the pro-
jected diabetes burden. Although the
majority of adults with diabetes have
T2DM, the majority of youth with diabe-
tes currently have T1DM. On the other
hand, T2DM may be becoming more
common in adolescents, especially
among minority youth (2,3).
There is substantial variation in the
incidence of T1DM and T2DM across
the major racial/ethnic groups in the
U.S. The incidence of T1DM is highest
among non-Hispanic whites (NHWs)
and lowest in American Indians (3). In
contrast, T2DM disproportionally affects
individuals from all racial/ethnic minority
groups (3). Therefore, changes in the
race/ethnicity distribution of the U.S.
population will substantially impact the
absolute number of individuals living
with T1DM or T2DM. This makes even
more compelling the need for diabetes
type–specific projections.
To overcome the limitations of pre-
vious studies and provide contemporary
estimates of the national type-specific
burden of diabetes in youth, we construc-
ted a system of dynamic equations that
incorporate diabetes prevalence and in-
cidence, as well as birth, migration, and
mortality estimates. These equations
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model the future burden of diabetes in
U.S. youth aged,20 years through 2050.
In addition, we perform sensitivity anal-
yses to assess the impact of increases in
the incidence and/or changes in the risk of




The data sources for this study include the
U.S. Census Bureau (6) and the SEARCH
study (2,3,7–11). Census data include es-
timates of the 2001 U.S. population by
ages (0, 1, 2,. . .,19 years), race/ethnicity
(NHW, non-Hispanic black [NHB], His-
panic, Asian and Pacific Islander [API],
American Indian/Alaska Native [AIAN]),
and sex, as well as projection estimates of
births, deaths, and net migration by the
same dimensions for the years 2002–
2050. For each of these components of
population changedfertility, mortality
and net migrationdthe census applied
three different assumptions to forecast
the future population size. We used the
series using the middle assumption for
each of these components, also desig-
nated as the middle series. SEARCH data
include diabetes prevalence in 2001 and
incidence from 2002 to 2007 collected
from geographically defined populations
in Ohio, Colorado, South Carolina, and
Washington, as well as Indian Health
Service beneficiaries from four American
Indian populations, and enrollees in man-
aged health care plans in California and
Hawaii. SEARCH is a multicenter study
that began in 2001 and is conducting
population-based ascertainment of youth
aged,20 years with clinically diagnosed,
nongestational diabetes. Institutional re-
view board(s) for each site approved the




2001 prevalence estimation. We used
Poisson regression to estimate T1DM and
T2DM prevalence as a function of age
(0,1,. . .,19 years), race/ethnicity (NHW,
NHB, Hispanic, API, AIAN), and sex. The
Bayesian information criterion was used
to select the best fitting models (12). The
Bayesian information criterion selects a
model from a collection of possible non-
nested models by maximizing the likeli-
hood but with a penalty for higher
dimensional models. Posterior predictive
checking was used to assess model
consistency with the data (13). We used
the deviance function as a test measure
and calculated the “Bayesian P value.”
Bayesian P values do not work like the
more common frequentist P values; values
between 0.1 and 0.9 indicate good model
fit (14). Models were fit using Bayesian
methods inWinBUGS (15). The finalmod-
els included a cubic spline for age (knots at
0, 9, and 19 years), race/ethnicity, and sex.
Posterior predictive checking yielded
Bayesian P values equal to 0.39 and 0.22,
indicating good model fit for T1DM and
T2DM, respectively. Our estimates of the
2001 T1DM and T2DM prevalence were
themeans of the posterior distributions ob-
tained from fitting the final models.
2002 incidence rate estimation. From a
population size of 30,549,412 person-
years in 2002 through 2007, SEARCH
identified 6,164 incident cases of T1DM
and 1,534 incident cases of T2DM. We
used Poisson regression to estimate
T1DM and T2DM incidence as a function
of age (0,1,. . .,19 years), race/ethnicity
(NHW, NHB, Hispanic, API, AIAN),
sex, and calendar year. We were primarily
interested in incidence estimates for the
year 2002. Including 6 years of data
with random effects by year improved
the year 2002 estimates by “borrowing
strength” from the other years. The final
models included a cubic spline for age
(knots at 0, 9, and 19 years), race, sex,
age by sex interactions, and random ef-
fects of calendar year. Posterior predictive
checking yielded Bayesian P values equal
to 0.29 and 0.12, indicating good model
fit for T1DM and T2DM, respectively.
Our estimates of the 2002 T1DM and
T2DM incidence rates were the means of
the posterior distributions obtained from
fitting the final models.
Projection model. We constructed dy-
namic models consisting of systems of
difference equations similar to models de-
scribed previously (16,17). In these mod-
els, theU.S. population aged 0 to 19years is
modeled at 1-year intervals starting at year
2001 and ending at year 2050. Specifically,
we defined numbers of individuals in var-
ious disease states (diabetes, no diabetes,
and death). The mathematical details are
presented in Supplementary Appendix 1.
Sensitivity analyses. We conducted sen-
sitivity analyses by varying both relative
risks of death in youth with diabetes
versus nondiabetic youth and incidence
rate projections for T1DM and T2DM.
Two scenarios were considered for rela-
tive risks of death: 1) the relative risks of
death for youth in the age-group ,20
years with T1DM or T2DM are equal to
one, i.e., death rates by age, race/ethnicity,
and sex for persons with and without di-
abetes are equal to the census projected
death rates; 2) death rates of youth with
diabetes are higher than those without di-
abetes with a relative risk equal to 1.5.
Two scenarios for T1DM incidence rates
were considered: 1) constant incidence
over time at 2002 levels (baseline sce-
nario); 2) yearly percentage increases of
3.5, 2.2, 1.8, and 2.1% by age-groups 0–
4 years, 5–9 years, 10–14 years, and 15–
19 years (as seen in a previous study
from Colorado [18]), respectively, were
applied to all 10 race-sex combinations.
Correspondingly, two scenarios for
T2DM incidence rates were considered:
1) constant incidence over time at 2002
levels (baseline scenario); 2) a yearly
2.3% increase applied uniformly to all
ages (0–19 years) for each of the 10 race-
sex combinations. This increase re-
presents the overall increase of T1DM
registered in the Colorado youth popula-
tion (18).
RESULTSdOur estimates of the 2002
T1DM and T2DM incidence rates by age
and race/ethnicity from fitting the final
models are presented in Fig. 1. The inci-
dence of T1DM peaks around the age of
10 years and is highest among NHWs fol-
lowed by NHBs, Hispanics, APIs, and
AIANs (Fig. 1A). The incidence of
T2DM peaks around 14 years of age.
AIAN youth have the highest incidence
rate, followed by NHBs, Hispanics, APIs,
and NHWs (Fig. 1B).
We used these incidence rates in the
projection model for each year from 2002
through 2050 in the baseline scenario,
where we assume constant incidence rates
over time.
Baseline scenario
Table 1 shows the projected number
of youth with T1DM and T2DM by race/
ethnicity for selected years. The model
forecasts that the number of youth with
T1DM will increase by 23%, from
166,018 in 2010 to 203,385 in 2050. Due
to the absolute increases in the numbers of
minority youths in the population as pro-
jected by the U.S. Census, this increase is
primarily driven by these youths. In
2010, NHWs represented 71% of all
youth with T1DM, but by 2050 this pro-
portion will decrease to 55%. Over the
40-year period, the number of Hispanic
youth with T1DM is projected to in-
crease 2.5-fold. The overall prevalence
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of T1DM remains largely unchanged
from 1.97/1,000 in 2010 to 1.80/1,000
in 2050, a decrease of 9%, reflecting the
lower incidence of T1DM among youth
from minority groups compared with
NHW youth.
The model estimated that in 2010
20,203 youth in the U.S. had T2DM.
Youth of minority groups represented the
majority of T2DM cases, while 25% were
NHW. The number of youth with T2DM
is projected to increase to 30,111 by
2050. As for T1DM, this increase is driven
largely by the increase in the population
of youth of minority groups. By 2050
Hispanics are estimated to represent 50%
of U.S. youth aged,20 years with T2DM.
Between 2010 and 2050, the overall prev-
alence of T2DM may increase by 13%,
from 0.24/1,000 to 0.27/1,000.
Increased incidence scenario
Table 2 presents the results of the sensi-
tivity analyses in which the incidence
rates of T1DM and T2DM increase while
the relative risk of death is equal to 1.0.
Under this scenario, the model projects
the number of youth with T1DM will
increase 3.3-fold, from 179,388 in 2010
to 587,488 in 2050. The number of youth
with T1DM will increase 6.6-fold in His-
panics, 5.4-fold in APIs, 4.4-fold in
AIANs, 3.0-fold in NHBs, and 2.5-fold
in NHWs. The prevalence will increase
by 144%, from 2.13/1,000 to 5.20/
1,000, with the highest estimate still
among NHW youth (7.04/1,000).
Under the scenario of an annual in-
crease of 2.3% in the incidence of T2DM,
the model indicates that, in the U.S., in
2010 there were 22,820 youth aged ,20
years with T2DM. By 2050, our model
predicts that this number will almost qua-
druple, to 84,131, with Hispanics repre-
senting 50% and NHBs 27% of all youth
with T2DM. On the basis of our projec-
tions, the prevalence will rise from 0.27/
1,000 in 2010 to 0.75/1,000 in 2050, an
increase of 178%. The prevalence will be
highest in NHBs (1.63/1,000) and lowest
in NHWs (0.28/1,000).
For both T1DM and T2DM, the dif-
ferences in the numbers of youth with
diabetes from the baseline scenario are
due to the increasing incidence rates over
baseline.
Under the increasing incidence sce-
nario and the baseline scenario, when we
set the relative risk of death at 1.5 for
youth with either T1DM or T2DM di-
abetes, results were virtually identical
(data not shown).
CONCLUSIONSdWe have estimated
the future burden of diabetes in youth by
type in themajor race/ethnic groups in the
U.S., using the most recent population-
based estimates of diabetes incidence and
prevalence and taking into account de-
mographic changes over time. Our model
projected that over the next 40 years, at
the current incidence rates, the number
of youth with T1DM and T2DM may
increase by 23% and 49%, respectively.
However, if the incidence of T1DM or
T2DM increases, there may be more
than a threefold increase in the number
of youth with T1DM and about a fourfold
increase in the number of youth with
T2DM, especially among minority youth.
Very little is known about effective
prevention of T1DM, and more research
is needed. However, T2DM can be
prevented in high risk adults. Additional
research is needed to examine the most
effective methods for T2DM prevention in
youth and should address strategies ap-
plicable to obesity prevention and control,
as well as strategies for youth at high risk
for T2DM. The projected increase in the
Figure 1dEstimated 2002 incidence of T1DM (A) and T2DM (B) among U.S. individuals aged
,20 years by age and race/ethnicity.
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prevalence of T2DM should serve as a call
to action so that by 2050 the actual
number of affected youth will fall mark-
edly short of our projections.
Because of the early age of onset and
longer diabetes duration, children and ado-
lescents are at risk for developing diabetes-
related complications at a younger age. As
these youth age, this profoundly affects
their productivity, quality of life, and life
expectancy and increases health care costs.
Even in childhood, the medical expendi-
tures of youth with diabetes are approxi-
mately 6.2 times of those without diabetes
(19). Thehealth care system and society as a
whole will need to plan and prepare for the
delivery of quality health care to meet the
needs of the growing number of youth with
diabetes. Thismay need to include the train-
ing of additional health care professionals
to treat and manage children and adoles-
cents with T1DM and T2DM.
Strengths of the current study include
the use of contemporary population-
based estimates of the prevalence and
incidence of T1DM and T2DM from the
SEARCH study for the major race/ethnic
groups in the U.S. This enabled us to
quantify race/ethnicity–specific future di-
abetes burden. Prevalence and incidence
estimates were based on physician’s diag-
nosis of T1DM or T2DM, and case defini-
tions met consistent eligibility criteria
(2,3). Moreover, physician’s diagnosis of
diabetes type was in good agreement with
the etiologic biochemical and clinical
characteristics of the two major types of
diabetes (20).
The projections have some limita-
tions. First, the recent estimated increase
in the incidence of T1DM is limited and
only available in one U.S. study conducted
in Colorado (18). The Colorado study
found a slightly lower annual increase in
T1DM incidence among youth than a
large registry-based study conducted in
17 European countries (EURODIAB;
overall yearly average increase 2.3% in
Colorado vs. 3.9% in Europe) (18,21).
However, the pattern of the increase in
Colorado was similar to that observed in
Europe, with children younger than 5
years old experiencing the greatest relative
increase. If the actual rate of increase in the
Table 1dProjections of the number of individuals aged <20 years with T1DM or T2DM and prevalence estimates* for selected years, by race/
ethnicity under baseline scenario†
Year
Race/ethnicity
NHW NHB Hispanic API AIAN Total
T1DM
2010 117,523 (2.45) 19,640 (1.60) 25,572 (1.35) 2,814 (0.70) 469 (0.46) 166,018 (1.97)
2020 115,989 (2.43) 19,373 (1.54) 35,139 (1.44) 3,661 (0.75) 570 (0.49) 174,732 (1.93)
2030 116,735 (2.46) 20,631 (1.57) 43,206 (1.43) 4,195 (0.74) 656 (0.51) 185,423 (1.90)
2040 113,405 (2.46) 21,051 (1.56) 53,063 (1.44) 4,905 (0.74) 693 (0.50) 193,117 (1.85)
2050 111,576 (2.44) 21,869 (1.55) 63,413 (1.45) 5,765 (0.74) 762 (0.50) 203,385 (1.80)
T2DM
2010 5,095 (0.11) 7,686 (0.63) 6,162 (0.33) 757 (0.19) 503 (0.50) 20,203 (0.24)
2020 4,792 (0.10) 7,179 (0.57) 8,251 (0.34) 932 (0.19) 509 (0.44) 21,663 (0.24)
2030 4,891 (0.10) 7,769 (0.59) 10,203 (0.34) 1,080 (0.19) 608 (0.47) 24,551 (0.25)
2040 4,788 (0.10) 7,971 (0.59) 12,524 (0.34) 1,248 (0.19) 645 (0.47) 27,176 (0.26)
2050 4,659 (0.10) 8,209 (0.58) 15,074 (0.34) 1,473 (0.19) 696 (0.46) 30,111 (0.27)
*Numbers in parentheses are the estimated prevalence of T1DM or T2DM per 1,000. †Assumes constant incidence of T1DM and T2DM over time and relative risk of
death equal to 1.0.
Table 2dProjections of the number of individuals aged <20 years with T1DM or T2DM and prevalence estimates* for selected years, by race/
ethnicity under increased incidence rate scenario†
Year
Race/ethnicity
NHW NHB Hispanic API AIAN Total
T1DM
2010 126,910 (2.65) 21,174 (1.72) 27,745 (1.47) 3,048 (0.76) 511 (0.50) 179,388 (2.13)
2020 156,537 (3.28) 26,164 (2.08) 47,336 (1.94) 4,915 (1.01) 775 (0.67) 235,727 (2.60)
2030 201,914 (4.26) 35,705 (2.71) 74,840 (2.48) 7,232 (1.28) 1,141 (0.89) 320,832 (3.28)
2040 252,478 (5.47) 46,928 (3.48) 118,527 (3.21) 10,922 (1.64) 1,558 (1.13) 430,413 (4.11)
2050 322,214 (7.04) 63,232 (4.48) 183,212 (4.18) 16,598 (2.14) 2,232 (1.46) 587,488 (5.20)
T2DM
2010 5,756 (0.12) 8,680 (0.71) 6,965 (0.37) 853 (0.21) 566 (0.56) 22,820 (0.27)
2020 6,798 (0.14) 10,179 (0.81) 11,693 (0.48) 1,320 (0.27) 723 (0.62) 30,713 (0.34)
2030 8,698 (0.18) 13,816 (1.05) 18,135 (0.60) 1,918 (0.34) 1,083 (0.84) 43,650 (0.45)
2040 10,670 (0.23) 17,766 (1.32) 27,919 (0.76) 2,782 (0.42) 1,441 (1.04) 60,578 (0.58)
2050 13,009 (0.28) 22,932 (1.63) 42,121 (0.96) 4,118 (0.53) 1,951 (1.28) 84,131 (0.75)
*Numbers in parentheses are the estimated prevalence of T1DM or T2DM per 1,000. †The incidence of T1DM and T2DM increase (see RESEARCHDESIGNANDMETHODS)
and relative risk of death equal to 1.0.
2518 DIABETES CARE, VOLUME 35, DECEMBER 2012 care.diabetesjournals.org
Projections of diabetes burden in U.S. youth
U.S. is more similar to that observed in
Europe, then our projections may under-
estimate the future burden of T1DM in the
U.S. However, it should be noted that
EURODIAB included only children aged
0–15 years and the greatest relative in-
crease in the incidence rate was observed
in countries with low baseline incidence.
Second, in our study we applied the same
rate of increase across all race/ethnic
groups. The Colorado study population
included only NHWs and Hispanics, and
the overall rate of increase in Hispanics
was slightly lower than that of NHWs
(1.6 vs. 2.7% per year, respectively). The
U.S. Census projections indicate that the
proportion of the youth population of
NHW race/ethnicity will diminish from
62% in 2001 to 41% in 2050 (22). Be-
cause of this demographic shift and the
possibility that youth of other races/
ethnicities than NHW may experience a
lower increase in the incidence, it is pos-
sible that the number of youth with
T1DM could be lower than that estimated
by our study under the increasing inci-
dence scenario. Third, we assumed con-
stant increases in T1DM incidence over
time and did not account for the possible
effect of yet to be identified primary pre-
vention strategies that may influence our
predicted number of youth with T1DM.
Given our current knowledge, the in-
creased incidence scenario should be
taken with caution. However, we would
like to point out that recent findings from
Europe indicated a constant linear trend
over a 15-year period (21) or, starting in
the early 1990s, even a steeper increase
(23).
Finally, because of the lack of pop-
ulation-based estimates of T2DM inci-
dence trends in youth aged ,20 years,
we used a yearly increase of 2.3% in our
increasing incidence scenario, based on
the overall increase of T1DM in the
Colorado study (18). In the Pima
Indians, a population at very high risk of
developing T2DM (24), among youth
aged 5–14 years, between 1965 and
2003 the incidence of T2DM increased
almost sixfold (25). In Finnish adoles-
cents and young adults (aged 15–39
years) during a 10-year period from
1992 to 2002, the incidence of T2DM in-
creased on average by 4.3% per year,
while that of T1DM increased by 3.9%
per year (26). Obesity is a major risk fac-
tor for the development of T2DM. Since
the 1980s, obesity prevalence among U.S.
children and adolescents tripled; how-
ever, recent national data indicate that
during the last decade obesity prevalence
may be leveling off at 17% (27). If obesity
remains stable for the next 40 years, it is
plausible that the current T2DM inci-
dence rate will remain steady. However,
even under this scenario, the number of
youth with T2DM may increase by 49%.
On the other hand, implementation of in-
terventions for the prevention of child-
hood obesity at the individual or
population level may result in decreasing
T2DM incidence over time (28,29).
In both scenarios in our study, in-
creasing the relative risk of death to 1.5
did not affect our estimates. This might
be partially explained by the very low
number of diabetes-related deaths in this
age-group (1.15 per million youths) (30).
Our projections suggest a shift in the
proportional distribution of racial/ethnic
groups among youth with T1DM. By
2050, about half of T1DM youths will
be of minority race/ethnic groups. This
change may influence potential trends in
clinical presentation, treatment patterns,
and quality of care. Minority youth are
more likely to be overweight or obese (27)
and this may lead to a misdiagnosis of
T2DM. Among SEARCH study partici-
pants, minority youth with T1DM were
significantly more likely to have poor glu-
cose control (glycated hemoglobin.9%)
than NHW youth (31). Minority youth
with T1DM are also more likely to live
in households with low income and pa-
rental education (7–11). This in turn may
affect their access to and quality of health
care (32,33). Because of the changing de-
mographics of the youth population with
T1DM, health care policies and delivery
systems need to assure that less advan-
taged youth receive appropriate care.
Our projections indicate a serious
picture of the future national diabetes
burden in youth. Even if the incidence
remains at 2002 levels, because of the
population growth projected by the U.S.
Census the future numbers of youth with
diabetes is projected to increase, resulting
in increased health care needs and costs.
Future planning should include strategies
for implementing childhood obesity pre-
vention programs and primary preven-
tion programs for youth at risk for
developing T2DM. Likewise, to prevent
future human suffering and health care
costs, effective interventions for the pre-
vention of diabetes-related complications
should be available to all youth with
diabetes (34). At the same time, it is cru-
cial to continuously monitor diabetes
trends at the population level, as well as
complications and quality of care among
youth.
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